Leukocyte Growth Factor class drugs
2 results
Nyvepria (pegfilgrastim-apgf)
(pegfilgrastim-apgf)Pfizer Laboratories Div Pfizer Inc
Usage: NYVEPRIA is indicated for reducing the incidence of infection, specifically febrile neutropenia, in patients with non-myeloid malignancies undergoing myelosuppressive anti-cancer treatment. It is not intended for mobilizing peripheral blood progenitor cells for stem cell transplantation.
Rolvedon (eflapegrastim-xnst)
(eflapegrastim-xnst)Spectrum Pharmaceuticals, Inc.
Usage: Rolvedon is indicated to reduce the incidence of febrile neutropenia in adult patients with non-myeloid malignancies undergoing myelosuppressive cancer treatment. It is not intended for mobilizing peripheral blood progenitor cells for stem cell transplantation.